ID 4V04A STANDARD; PRT; 309 AA. DT CONVERTED FROM PDB (SEQRES) 4V04 DE FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFE DE R SYNDROME), ISOFORM CRA_B OS HOMO SAPIENS CC EXPDTA X-RAY DIFFRACTION CC RESOLU 2.120 CC R-Factor 0.188 FT #SUB 126 582 GLU A 275 731 MET B Protein S 1 FT #SUB 126 582 GLU A 279 735 ASP B Protein S 3 FT #SUB 126 582 GLU A 282 738 HIS B Protein S 3 FT #SUB 127 583 TYR A 274 730 TYR B Protein S 2 FT #SUB 127 583 TYR A 275 731 MET B Protein S 4 FT #SUB 127 583 TYR A 278 734 ARG B Protein A 17 FT #SUB 128 584 SER A 278 734 ARG B Protein B 1 FT #SUB 246 702 PRO A 248 704 VAL B Protein B 1 FT #SUB 246 702 PRO A 256 712 LEU B Protein B 1 FT #SUB 246 702 PRO A 261 717 HIS B Protein S 3 FT #SUB 247 703 GLY A 248 704 VAL B Protein B 4 FT #SUB 247 703 GLY A 249 705 PRO B Protein B 1 FT #SUB 247 703 GLY A 252 708 GLU B Protein B 3 FT #SUB 248 704 VAL A 246 702 PRO B Protein S 1 FT #SUB 248 704 VAL A 247 703 GLY B Protein A 4 FT #SUB 248 704 VAL A 248 704 VAL B Protein S 1 FT #SUB 249 705 PRO A 247 703 GLY B Protein S 1 FT #SUB 249 705 PRO A 249 705 PRO B Protein S 4 FT #SUB 252 708 GLU A 247 703 GLY B Protein S 2 FT #SUB 256 712 LEU A 246 702 PRO B Protein S 1 FT #SUB 261 717 HIS A 246 702 PRO B Protein S 3 FT #SUB 265 721 LYS A 267 723 SER B Protein A 4 FT #SUB 267 723 SER A 265 721 LYS B Protein A 6 FT #SUB 267 723 SER A 266 722 PRO B Protein S 1 FT #HET 14 470 ARG A 4 1769 EDO A A 5 FT #HET 15 471 TRP A 3 1768 EDO A S 1 FT #HET 15 471 TRP A 4 1769 EDO A S 1 FT #HET 36 492 VAL A 7 1772 0LI A S 2 FT #HET 56 512 ALA A 7 1772 0LI A S 3 FT #HET 58 514 LYS A 7 1772 0LI A A 5 FT #HET 75 531 GLU A 7 1772 0LI A S 10 FT #HET 78 534 MET A 7 1772 0LI A S 4 FT #HET 79 535 MET A 3 1768 EDO A A 8 FT #HET 79 535 MET A 7 1772 0LI A S 1 FT #HET 82 538 ILE A 3 1768 EDO A S 2 FT #HET 83 539 GLY A 3 1768 EDO A B 7 FT #HET 83 539 GLY A 10 1775 SO4 A B 2 FT #HET 84 540 LYS A 3 1768 EDO A A 2 FT #HET 84 540 LYS A 10 1775 SO4 A A 5 FT #HET 88 544 ILE A 3 1768 EDO A S 1 FT #HET 89 545 ILE A 7 1772 0LI A S 1 FT #HET 90 546 ASN A 3 1768 EDO A A 6 FT #HET 91 547 LEU A 3 1768 EDO A A 4 FT #HET 105 561 VAL A 7 1772 0LI A S 6 FT #HET 106 562 GLU A 7 1772 0LI A B 2 FT #HET 107 563 TYR A 7 1772 0LI A A 4 FT #HET 108 564 ALA A 7 1772 0LI A A 9 FT #HET 110 566 LYS A 5 1770 EDO A A 4 FT #HET 114 570 ARG A 9 1774 SO4 A S 7 FT #HET 116 572 TYR A 5 1770 EDO A B 1 FT #HET 120 576 ARG A 5 1770 EDO A S 4 FT #HET 121 577 ARG A 11 1776 SO4 A S 4 FT #HET 137 593 GLU A 5 1770 EDO A S 1 FT #HET 158 614 LEU A 7 1772 0LI A S 3 FT #HET 159 615 ALA A 1 1766 EDO A S 1 FT #HET 162 618 LYS A 8 1773 SO4 A A 7 FT #HET 163 619 CYS A 7 1772 0LI A S 3 FT #HET 164 620 ILE A 7 1772 0LI A B 4 FT #HET 165 621 HIS A 7 1772 0LI A A 7 FT #HET 166 622 ARG A 7 1772 0LI A S 3 FT #HET 171 627 ARG A 9 1774 SO4 A S 8 FT #HET 174 630 LEU A 7 1772 0LI A S 6 FT #HET 183 639 ILE A 7 1772 0LI A A 4 FT #HET 184 640 ALA A 7 1772 0LI A A 7 FT #HET 185 641 ASP A 7 1772 0LI A A 15 FT #HET 186 642 PHE A 7 1772 0LI A S 1 FT #HET 187 643 GLY A 7 1772 0LI A B 28 FT #HET 188 644 LEU A 7 1772 0LI A B 13 FT #HET 201 657 THR A 9 1774 SO4 A S 4 FT #HET 203 659 ASN A 9 1774 SO4 A S 4 FT #HET 205 661 ARG A 9 1774 SO4 A S 14 FT #HET 210 666 TRP A 9 1774 SO4 A S 2 FT #HET 223 679 HIS A 1 1766 EDO A S 2 FT #HET 223 679 HIS A 8 1773 SO4 A S 6 FT #HET 228 684 TRP A 2 1767 EDO A S 2 FT #HET 242 698 GLY A 11 1776 SO4 A B 1 FT #HET 243 699 SER A 11 1776 SO4 A A 5 FT #HET 245 701 TYR A 2 1767 EDO A S 5 FT #HET 259 715 GLU A 6 1771 EDO A A 6 FT #HET 260 716 GLY A 6 1771 EDO A B 2 FT #HET 261 717 HIS A 6 1771 EDO A A 9 FT #HET 262 718 ARG A 2 1767 EDO A A 4 FT #HET 263 719 MET A 2 1767 EDO A A 6 FT #HET 281 737 TRP A 2 1767 EDO A S 11 FT #HET 290 746 THR A 1 1766 EDO A A 6 FT #HET 291 747 PHE A 1 1766 EDO A A 9 FT #HET 292 748 LYS A 1 1766 EDO A A 3 FT DISORDER 1 6 FT DISORDER 31 33 FT DISORDER 129 129 FT DISORDER 189 194 CC Miss-BB 1 CC Miss-SC 1 CC SEQUENCE 292 AA (ATOM); CC YELPEDPRWE LPRDRLVLGK PLGEGQVVLA EAIGLDKDKP NRVTKVAVKM LKSDATEKDL CC SDLISEMEMM KMIGKHKNII NLLGACTQDG PLYVIVEYAS KGNLREYLQA RRPPGLEYSP CC SHNPEEQLSS KDLVSCAYQV ARGMEYLASK KCIHRDLAAR NVLVTEDNVM KIADFGLIDY CC YKKTTNGRLP VKWMAPEALF DRIYTHQSDV WSFGVLLWEI FTLGGSPYPG VPVEELFKLL CC KEGHRMDKPS NCTNELYMMM RDCWHAVPSQ RPTFKQLVED LDRIVALTSN QE CC !---- CC ALIGNMENT OF SEQRES AND ATOMRES CC SEQRES GAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPN CC ATOM ------YELPEDPRWELPRDRLVLGKPLGE---GQVVLAEAIGLDKDKPN CC ************************ ***************** CC SEQRES RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP CC ATOM RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP CC ************************************************** CC SEQRES LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQ CC ATOM LYVIVEYASKGNLREYLQARRPPGLEYS-NPSHNPEEQLSSKDLVSCAYQ CC **************************** ********************* CC SEQRES VARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK CC ATOM VARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL------IDYYKK CC ************************************** ****** CC SEQRES TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV CC ATOM TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV CC ************************************************** CC SEQRES EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR CC ATOM EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR CC ************************************************** CC SEQRES IVALTSNQE CC ATOM IVALTSNQE CC ********* SQ SEQUENCE 309 AA; MW; CN; GAGVSEYELP EDPRWELPRD RLVLGKPLGE GAFGQVVLAE AIGLDKDKPN RVTKVAVKML KSDATEKDLS DLISEMEMMK MIGKHKNIIN LLGACTQDGP LYVIVEYASK GNLREYLQAR RPPGLEYSYN PSHNPEEQLS SKDLVSCAYQ VARGMEYLAS KKCIHRDLAA RNVLVTEDNV MKIADFGLAR DIHHIDYYKK TTNGRLPVKW MAPEALFDRI YTHQSDVWSF GVLLWEIFTL GGSPYPGVPV EELFKLLKEG HRMDKPSNCT NELYMMMRDC WHAVPSQRPT FKQLVEDLDR IVALTSNQE // ID 4V04B STANDARD; PRT; 309 AA. DT CONVERTED FROM PDB (SEQRES) 4V04 DE FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFE DE R SYNDROME), ISOFORM CRA_B OS HOMO SAPIENS CC EXPDTA X-RAY DIFFRACTION CC RESOLU 2.120 CC R-Factor 0.188 FT #SUB 246 702 PRO B 248 704 VAL A Protein B 1 FT #SUB 246 702 PRO B 256 712 LEU A Protein B 1 FT #SUB 246 702 PRO B 261 717 HIS A Protein S 3 FT #SUB 247 703 GLY B 248 704 VAL A Protein B 4 FT #SUB 247 703 GLY B 249 705 PRO A Protein B 1 FT #SUB 247 703 GLY B 252 708 GLU A Protein B 2 FT #SUB 248 704 VAL B 246 702 PRO A Protein S 1 FT #SUB 248 704 VAL B 247 703 GLY A Protein A 4 FT #SUB 248 704 VAL B 248 704 VAL A Protein S 1 FT #SUB 249 705 PRO B 247 703 GLY A Protein S 1 FT #SUB 249 705 PRO B 249 705 PRO A Protein S 4 FT #SUB 252 708 GLU B 247 703 GLY A Protein S 3 FT #SUB 256 712 LEU B 246 702 PRO A Protein S 1 FT #SUB 261 717 HIS B 246 702 PRO A Protein S 3 FT #SUB 265 721 LYS B 267 723 SER A Protein A 6 FT #SUB 266 722 PRO B 267 723 SER A Protein B 1 FT #SUB 267 723 SER B 265 721 LYS A Protein S 4 FT #SUB 274 730 TYR B 127 583 TYR A Protein S 2 FT #SUB 275 731 MET B 126 582 GLU A Protein S 1 FT #SUB 275 731 MET B 127 583 TYR A Protein A 4 FT #SUB 278 734 ARG B 127 583 TYR A Protein S 17 FT #SUB 278 734 ARG B 128 584 SER A Protein S 1 FT #SUB 279 735 ASP B 126 582 GLU A Protein S 3 FT #SUB 282 738 HIS B 126 582 GLU A Protein S 3 FT #HET 10 466 PRO B 15 1769 EDO B A 7 FT #HET 12 468 ASP B 15 1769 EDO B S 1 FT #HET 18 474 PRO B 14 1768 EDO B A 4 FT #HET 19 475 ARG B 14 1768 EDO B A 6 FT #HET 20 476 ASP B 14 1768 EDO B A 7 FT #HET 28 484 LEU B 17 1771 0LI B S 1 FT #HET 36 492 VAL B 17 1771 0LI B S 2 FT #HET 56 512 ALA B 17 1771 0LI B A 5 FT #HET 57 513 VAL B 17 1771 0LI B B 1 FT #HET 58 514 LYS B 17 1771 0LI B A 6 FT #HET 73 529 ILE B 15 1769 EDO B S 1 FT #HET 75 531 GLU B 17 1771 0LI B S 9 FT #HET 76 532 MET B 15 1769 EDO B S 2 FT #HET 77 533 GLU B 15 1769 EDO B S 7 FT #HET 78 534 MET B 17 1771 0LI B S 2 FT #HET 79 535 MET B 17 1771 0LI B S 1 FT #HET 80 536 LYS B 15 1769 EDO B S 2 FT #HET 89 545 ILE B 17 1771 0LI B S 1 FT #HET 96 552 THR B 15 1769 EDO B S 1 FT #HET 105 561 VAL B 17 1771 0LI B S 9 FT #HET 106 562 GLU B 17 1771 0LI B B 2 FT #HET 107 563 TYR B 17 1771 0LI B A 4 FT #HET 108 564 ALA B 17 1771 0LI B A 9 FT #HET 110 566 LYS B 16 1770 EDO B A 6 FT #HET 114 570 ARG B 18 1772 SO4 B S 5 FT #HET 116 572 TYR B 16 1770 EDO B B 2 FT #HET 120 576 ARG B 16 1770 EDO B S 7 FT #HET 141 597 SER B 13 1767 EDO B S 4 FT #HET 144 600 LEU B 13 1767 EDO B S 1 FT #HET 158 614 LEU B 17 1771 0LI B S 3 FT #HET 163 619 CYS B 17 1771 0LI B S 2 FT #HET 164 620 ILE B 17 1771 0LI B B 4 FT #HET 165 621 HIS B 17 1771 0LI B A 7 FT #HET 166 622 ARG B 17 1771 0LI B S 3 FT #HET 171 627 ARG B 18 1772 SO4 B S 7 FT #HET 174 630 LEU B 17 1771 0LI B S 6 FT #HET 183 639 ILE B 17 1771 0LI B A 4 FT #HET 184 640 ALA B 17 1771 0LI B A 6 FT #HET 185 641 ASP B 17 1771 0LI B A 16 FT #HET 186 642 PHE B 17 1771 0LI B S 4 FT #HET 187 643 GLY B 17 1771 0LI B B 28 FT #HET 188 644 LEU B 17 1771 0LI B A 14 FT #HET 201 657 THR B 18 1772 SO4 B S 5 FT #HET 203 659 ASN B 18 1772 SO4 B S 5 FT #HET 205 661 ARG B 18 1772 SO4 B S 13 FT #HET 210 666 TRP B 18 1772 SO4 B S 1 FT #HET 228 684 TRP B 12 1766 EDO B S 2 FT #HET 238 694 PHE B 13 1767 EDO B S 3 FT #HET 245 701 TYR B 12 1766 EDO B S 6 FT #HET 257 713 LEU B 12 1766 EDO B S 1 FT #HET 262 718 ARG B 12 1766 EDO B A 4 FT #HET 263 719 MET B 12 1766 EDO B A 6 FT #HET 268 724 ASN B 13 1767 EDO B A 6 FT #HET 269 725 CYS B 13 1767 EDO B B 3 FT #HET 270 726 THR B 13 1767 EDO B A 2 FT #HET 273 729 LEU B 13 1767 EDO B S 2 FT #HET 281 737 TRP B 12 1766 EDO B S 7 FT DISORDER 1 1 FT DISORDER 124 136 FT DISORDER 189 194 CC SEQUENCE 289 AA (ATOM); CC AGVSEYELPE DPRWELPRDR LVLGKPLGEG AFGQVVLAEA IGLDKDKPNR VTKVAVKMLK CC SDATEKDLSD LISEMEMMKM IGKHKNIINL LGACTQDGPL YVIVEYASKG NLREYLQARR CC PPEQLSSKDL VSCAYQVARG MEYLASKKCI HRDLAARNVL VTEDNVMKIA DFGLIDYYKK CC TTNGRLPVKW MAPEALFDRI YTHQSDVWSF GVLLWEIFTL GGSPYPGVPV EELFKLLKEG CC HRMDKPSNCT NELYMMMRDC WHAVPSQRPT FKQLVEDLDR IVALTSNQE CC !---- CC ALIGNMENT OF SEQRES AND ATOMRES CC SEQRES GAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPN CC ATOM -AGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPN CC ************************************************* CC SEQRES RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP CC ATOM RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP CC ************************************************** CC SEQRES LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQ CC ATOM LYVIVEYASKGNLREYLQARRPP-------------EQLSSKDLVSCAYQ CC *********************** ************** CC SEQRES VARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK CC ATOM VARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL------IDYYKK CC ************************************** ****** CC SEQRES TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV CC ATOM TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV CC ************************************************** CC SEQRES EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR CC ATOM EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR CC ************************************************** CC SEQRES IVALTSNQE CC ATOM IVALTSNQE CC ********* SQ SEQUENCE 309 AA; MW; CN; GAGVSEYELP EDPRWELPRD RLVLGKPLGE GAFGQVVLAE AIGLDKDKPN RVTKVAVKML KSDATEKDLS DLISEMEMMK MIGKHKNIIN LLGACTQDGP LYVIVEYASK GNLREYLQAR RPPGLEYSYN PSHNPEEQLS SKDLVSCAYQ VARGMEYLAS KKCIHRDLAA RNVLVTEDNV MKIADFGLAR DIHHIDYYKK TTNGRLPVKW MAPEALFDRI YTHQSDVWSF GVLLWEIFTL GGSPYPGVPV EELFKLLKEG HRMDKPSNCT NELYMMMRDC WHAVPSQRPT FKQLVEDLDR IVALTSNQE //